Subscribe to Newsletter

Evaluation of cell-free fetal DNA to determine fetal RhD status

Fetal Rhesus Factor D (RhD) genotyping is typically performed through non-invasive prenatal testing (NIPT) and is important in identifying RhD incompatibility between mother and child. 

The FetoGnost® Kit RHD from Ingenetix allows rapid, sensitive, and non-invasive fetal RhD genotyping of samples purified from maternal plasma of RhD-negative pregnant women, based on real-time PCR technology. In this app note, you will explore the compatibility of the FetoGnost® Kit RHD with extracted cffDNA obtained with the chemagic™ 360 instrument using RhD-positive or -negative plasma from blood donors.

>> Download app note as a PDF

Find out more on Revvity's website here

>Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Pathologist site. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register